These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 19037649

  • 1. Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves' ophthalmopathy.
    Khalilzadeh O, Mojazi Amiri H, Tahvildari M, Anvari M, Esteghamati A, Mobarra Z, Tehranchinia Z, Rashidi A, Amirzargar A.
    Arch Dermatol Res; 2009 Oct; 301(10):719-23. PubMed ID: 19037649
    [Abstract] [Full Text] [Related]

  • 2. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients.
    Esteghamati A, Khalilzadeh O, Mobarra Z, Anvari M, Tahvildari M, Amiri HM, Rashidi A, Solgi G, Parivar K, Nikbin B, Amirzargar A.
    Eur J Intern Med; 2009 Jul; 20(4):424-8. PubMed ID: 19524188
    [Abstract] [Full Text] [Related]

  • 3. Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene.
    Zhang Q, Yang YM, Lv XY.
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):887-91. PubMed ID: 17048303
    [Abstract] [Full Text] [Related]

  • 4. CTLA4 polymorphisms and ophthalmopathy in Graves' disease patients: association study and meta-analysis.
    Han S, Zhang S, Zhang W, Li R, Li Y, Wang Z, Xie Y, Mao Y.
    Hum Immunol; 2006 Aug; 67(8):618-26. PubMed ID: 16916658
    [Abstract] [Full Text] [Related]

  • 5. Graves' disease in Brazilian children and adults: lack of genetic association with CTLA-4 +49A>G polymorphism.
    Namo Cury A, Longui CA, Kochi C, Calliari LE, Scalissi N, Salles JE, Neves Rocha M, Barbosa de Melo M, Rezende Melo M, Monte O.
    Horm Res; 2008 Aug; 70(1):36-41. PubMed ID: 18493148
    [Abstract] [Full Text] [Related]

  • 6. CTLA-4 gene polymorphism and its association with Graves' disease in the Lebanese population.
    Nakkash-Chmaisse H, Makki RF, Abdelhamid E, Fakhoury H, Salti NN, Salti I.
    Eur J Immunogenet; 2004 Jun; 31(3):141-3. PubMed ID: 15182328
    [Abstract] [Full Text] [Related]

  • 7. 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease.
    Bicek A, Zaletel K, Gaberscek S, Pirnat E, Krhin B, Stopar TG, Hojker S.
    Hum Immunol; 2009 Oct; 70(10):820-4. PubMed ID: 19559744
    [Abstract] [Full Text] [Related]

  • 8. CTLA-4 (CD152) gene polymorphism at position 49 in exon 1 in Graves' disease in a Polish population of the Lower Silesian region.
    Frydecka I, Daroszewski J, Suwalska K, Zołedziowska M, Tutak A, Słowik M, Potoczek S, Dobosz T.
    Arch Immunol Ther Exp (Warsz); 2004 Oct; 52(5):369-74. PubMed ID: 15507878
    [Abstract] [Full Text] [Related]

  • 9. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese.
    Kamizono S, Hiromatsu Y, Seki N, Bednarczuk T, Matsumoto H, Kimura A, Itoh K.
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):759-64. PubMed ID: 10848881
    [Abstract] [Full Text] [Related]

  • 10. [Association of polymorphism of protein tyrosine phosphatase nonreceptor-22 gene with AITD].
    Yu ZY, Zhang JA, Maier HB, Wang Y, Xiao WX, Quan Y, Dong BN.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Aug; 24(8):804-7. PubMed ID: 18687223
    [Abstract] [Full Text] [Related]

  • 11. Polymorphisms of endothelin 1 (G5665T and T-1370G) and endothelin receptor type A (C+70G and G-231A) in Graves' disease.
    Aydın AF, Develi-İş S, Doğru-Abbasoğlu S, Vural P, Ozderya A, Karadağ B, Uysal M.
    Int Immunopharmacol; 2014 Jan; 18(1):198-202. PubMed ID: 24291390
    [Abstract] [Full Text] [Related]

  • 12. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
    Ulker M, Yazisiz V, Sallakci N, Avci AB, Sanlioglu S, Yegin O, Terzioglu E.
    Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
    [Abstract] [Full Text] [Related]

  • 13. Association of the interleukin (IL)-16 gene polymorphisms with Graves' disease.
    Gu XJ, Cui B, Zhao ZF, Chen HY, Li XY, Wang S, Ning G, Zhao YJ.
    Clin Immunol; 2008 Jun; 127(3):298-302. PubMed ID: 18394967
    [Abstract] [Full Text] [Related]

  • 14. Polymorphisms at +49A/G and CT60 sites in the 3' UTR of the CTLA-4 gene and APECED-related AIRE gene mutations analysis in sporadic idiopathic hypoparathyroidism.
    Goswami R, Gupta N, Ray D, Rani R, Tomar N, Sarin R, Vupputuri MR.
    Int J Immunogenet; 2005 Dec; 32(6):393-400. PubMed ID: 16313305
    [Abstract] [Full Text] [Related]

  • 15. CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease.
    Sallakci N, Bacanli A, Coskun M, Yavuzer U, Alpsoy E, Yegin O.
    Clin Exp Dermatol; 2005 Sep; 30(5):546-50. PubMed ID: 16045690
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X, Latif R, Bahn R, Tomer Y, Davies TF.
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [Abstract] [Full Text] [Related]

  • 19. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
    Pawlak-Adamska E, Frydecka I, Bolanowski M, Tomkiewicz A, Jonkisz A, Karabon L, Partyka A, Nowak O, Szalinski M, Daroszewski J.
    Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.